Misoprostol For Nulliparous Women Before Hysteroscopy

• Status: Unknown status
• Trial end date: 2011-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

To compare the impact of 400-microgram self-administered vaginal versus self-administered oral misoprostol at home on preoperative cervical ripening in nulliparous women prior to outpatient hysteroscopy.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Wenzhou Medical University
• Treatments: Misoprostol

Criteria

Inclusion Criteria:

• nulliparous women who are referred to outpatient hysteroscopy and who have given informed consent will be eligible for study recruitment.

Exclusion Criteria:

• women with a known allergy to misoprostol.